Targeting the respiratory muscles of fetal sheep for prenatal gene therapy for Duchenne muscular dystrophy

Am J Obstet Gynecol. 2005 Sep;193(3 Pt 2):1105-9. doi: 10.1016/j.ajog.2005.06.077.

Abstract

Objective: Duchenne muscular dystrophy (DMD) is a lethal degenerative muscular disease. Fetal gene therapy may correct the primary genetic defect. Our aim was to achieve expression of a reporter gene in the respiratory muscles of early gestation fetal sheep.

Study design: An adenovirus vector containing the beta-galactosidase reporter gene (AdRSVbetagal) was injected into the thoracic musculature (n = 3) and pleural cavity (n = 6) of fetal sheep (61-67 days' gestation) under ultrasound guidance. Tissues were harvested after 48 hours and site and intensity of beta-galactosidase expression were assessed.

Results: Limited transgene expression observed after a single injection was improved by multiple injections, but remained localized. Ultrasound-guided creation of a hydrothorax led to an increase in the intensity of beta-galactosidase expression (ELISA). X-gal staining and immunohistochemistry showed that vector spread was confined to the innermost intercostal musculature.

Conclusion: Ultrasound-guided injection can deliver gene therapy vectors to the fetal pleural cavity and achieve transduction of the respiratory muscles.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adenoviridae / genetics
  • Animals
  • Female
  • Genes, Reporter
  • Genetic Therapy / methods
  • Genetic Vectors / administration & dosage*
  • Hydrothorax
  • Immunohistochemistry
  • Injections, Intramuscular
  • Muscular Dystrophy, Duchenne / embryology
  • Muscular Dystrophy, Duchenne / therapy*
  • Pregnancy
  • Respiratory Muscles / metabolism*
  • Sheep
  • Transgenes / physiology
  • Ultrasonography, Prenatal
  • beta-Galactosidase / genetics
  • beta-Galactosidase / metabolism

Substances

  • beta-Galactosidase